Reckitt Mucinex Patent Gets Reprieve As Appeals Court Rules Against Perrigo

An appeals court decision against Perrigo further delays the private labeler's plans to launch a Mucinex equivalent, leaving the Reckitt Benckiser decongestant still unchallenged by generic competition

More from Archive

More from Pink Sheet